News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
809,137 Results
Type
Article (73924)
Company Profile (644)
Press Release (734569)
Section
Business (227265)
Career Advice (3711)
Deals (39280)
Drug Delivery (123)
Drug Development (89207)
Employer Resources (195)
FDA (17784)
Job Trends (17099)
News (387317)
Policy (38689)
Tag
Academia (2975)
Alliances (55839)
Alzheimer's disease (1413)
Approvals (17721)
Artificial intelligence (226)
Bankruptcy (396)
Best Places to Work (12630)
Biotechnology (440)
Breast cancer (233)
Cancer (1760)
Cardiovascular disease (144)
Career advice (3157)
CAR-T (134)
Cell therapy (373)
Clinical research (71296)
Collaboration (687)
Compensation (364)
COVID-19 (2831)
C-suite (163)
Data (1587)
Diabetes (226)
Diagnostics (6790)
Earnings (92427)
Employer resources (167)
Events (126991)
Executive appointments (577)
FDA (18676)
Funding (611)
Gene therapy (262)
GLP-1 (766)
Government (5029)
Healthcare (20802)
Infectious disease (2947)
Interviews (722)
IPO (17674)
Job creations (4986)
Job search strategy (2589)
Layoffs (515)
Legal (9877)
Lung cancer (266)
Manufacturing (258)
Medical device (14483)
Medtech (14488)
Mergers & acquisitions (21939)
Metabolic disorders (615)
Neuroscience (1854)
NextGen: Class of 2025 (7628)
Non-profit (5075)
Northern California (2035)
Obesity (349)
Opinion (257)
Patents (155)
People (63505)
Pharmaceutical (133)
Phase I (22024)
Phase II (31111)
Phase III (23441)
Pipeline (685)
Postmarket research (3255)
Preclinical (9666)
Radiopharmaceuticals (263)
Rare diseases (345)
Real estate (7133)
Regulatory (25605)
Research institute (2645)
Resumes & cover letters (579)
Southern California (1772)
Startups (4189)
United States (19039)
Vaccines (710)
Weight loss (264)
Date
Today (112)
Last 7 days (656)
Last 30 days (2697)
Last 365 days (37316)
2025 (3693)
2024 (37897)
2023 (42567)
2022 (53926)
2021 (58723)
2020 (57667)
2019 (51305)
2018 (39085)
2017 (36830)
2016 (37739)
2015 (43730)
2014 (38413)
2013 (34388)
2012 (36287)
2011 (36403)
2010 (35833)
Location
Africa (1187)
Arizona (223)
Asia (48235)
Australia (8301)
California (4788)
Canada (1679)
China (403)
Colorado (220)
Connecticut (236)
Europe (108785)
Florida (682)
Georgia (171)
Illinois (517)
Indiana (274)
Maryland (782)
Massachusetts (3792)
Michigan (217)
Minnesota (353)
New Jersey (1363)
New York (1359)
North Carolina (956)
Northern California (2035)
Ohio (178)
Pennsylvania (1095)
South America (1561)
Southern California (1772)
Texas (708)
Utah (146)
Washington State (496)
809,137 Results for "daewoong pharmaceutical co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson’s Disease
November 25, 2024
·
9 min read
Business
Daewoong Pharmaceutical Announces 2023 Financial Results
Daewoong Pharmaceutical, a global pharmaceutical company located in Seoul, announced its marvelous financial results for 2023.
February 6, 2024
·
5 min read
Business
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson’s Disease
HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-development agreement with NurrOn Pharmaceuticals Inc., a Boston-based preclinical-stage biopharma.
May 25, 2023
·
7 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Daewoong Pharmaceutical’s Bersiporocin Receives ‘Orphan Drug Designation’ in Europe to Treat Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical’s Bersiporocin (DWN12088) has been recognized as a significant advancement in treating idiopathic pulmonary fibrosis (IPF), a rare and debilitating disease.
January 29, 2024
·
2 min read
Business
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Verrica Pharmaceuticals Inc. today announced that it has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. (Torii), to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH® for the treatment of common warts.
May 15, 2024
·
9 min read
Press Releases
Daewoong Pharmaceutical Unveils ‘Innovative Drug Delivery Technologies’ in Milan--From World’s First Microneedle Therapy to Once-a-Month Obesity Treatment
October 10, 2024
·
3 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
1 of 80,914
Next
